Text Size
2 studies found for:    20979469 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: Neoplasms
Intervention: Genetic: Blood and tumor samples
2 Recruiting A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Conditions: Systemic Anaplastic Large-Cell Lymphoma;   Neoplasms;   Anaplastic Lymphoma Kinase, Human;   NSCLC
Interventions: Drug: PF-02341066;   Drug: Rifampin;   Drug: Ketoconazole
To Top

† Indicates status has not been verified in more than two years